Pediatr Surg Int. 2025 Aug 17;41(1):248. doi: 10.1007/s00383-025-06151-2.
ABSTRACT
PURPOSE: To investigate the effectiveness of an aggressive treatment strategy for meconium-related ileus (MRI) in extremely low birth weight infants (ELBWIs).
METHODS: Since April 2018, we have implemented a novel protocol, incorporating early Gastrografin injection, aggressive enema therapy, and early surgery without perforation (ES). Among 362 ELBWIs treated at our institute over the past 15 years, 91 with MRI were included in this study. We compared patient demographics, treatment details, and outcomes between the “Old” group (O, n = 56; treated before March 2018) and the “New” group (N, n = 35; treated after April 2018).
RESULTS: The O group showed higher perforation rates (21.4%; 12/56) than those of the N group (2.9%, 1/35) (p = 0.014). The surgical rates were 21.4% (12/56) and 14.3% (5/35) in the O and N groups, respectively (p = 0.581), while the ES rates were 0% (0/56) and 11.8% (4/35), respectively (p = 0.02). The N group had a significantly higher overall survival rate (100%, 35/35) than the O group (87.5%, 49/56) (p = 0.041). In the O group, all seven deaths were related to perforation.
CONCLUSIONS: Our aggressive MRI treatment was associated with reduced perforation rates and improved survival outcomes, demonstrating its effectiveness.
PMID:40819318 | DOI:10.1007/s00383-025-06151-2
